{
    "medicine_id": "de4c4b754b6ef3be47e600e5dee69833017b103d",
    "platform_id": "DB00826",
    "metadata": {
        "name": "Natacyn 50 mg 1mL Suspension drops",
        "composition": "50 mg 1mL Natamycin",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of fungal blepharitis conjunctivitis and keratitis caused by susceptible organisms including i Fusarium solani i keratitis",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Natamycin is an antifungal drug for topical ophthalmic administration It is a tetraene polyene antibiotic derived from i Streptomyces natalensis i It possesses in vitro activity against a variety of yeast and filamentous fungi including i Candida i i Aspergillus i i Cephalosporium i i Fusarium i and i Penicillium i Although the activity against fungi is dose related natamycin is predominantly fungicidal Natamycin is not effective in vitro against gram positive or gram negative bacteria Topical administration appears to produce effective concentrations of natamycin within the corneal stroma but not in intraocular fluid",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB14975",
                        "description": "The serum concentration of Voxelotor can be increased when it is combined with Natamycin"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "The serum concentration of Levamlodipine can be increased when it is combined with Natamycin"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Haloperidol can be increased when it is combined with Natamycin"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with Natamycin"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}